|4Dec 22, 4:18 PM ET

Gawlick Rainer 4

4 · Proto Labs Inc · Filed Dec 22, 2020

Insider Transaction Report

Form 4
Period: 2020-12-18
Transactions
  • Sale

    Common Stock

    2020-12-18$160.00/sh2,000$320,00824,259 total
  • Exercise/Conversion

    Common Stock

    2020-12-18$53.34/sh+2,000$106,68026,259 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2020-12-182,000715 total
    Exercise: $53.34Exp: 2023-05-23Common Stock (2,000 underlying)
Footnotes (3)
  • [F1]Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2020.
  • [F2]Fully vested.
  • [F3]Reflects the weighted average price of 2,000 shares of common stock of Proto Labs, Inc. sold by the reporting person on December 18, 2020 with sale prices ranging from $160.00 to $160.09 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4